Eumana Home Dialysis, Inc.
NPI #1881701480

End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility located in Houston, TX

0
1313 La Concha Ln
Houston, TX 77054-1809
(713) 668-2744

About

Eumana Home Dialysis, Inc. is a End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility (taxonomy code 261QE0700X) located in Houston, Texas. Eumana Home Dialysis, Inc.'s NPI Number is #1881701480 and has been listed in the NPI registry for 18 years. Eumana Home Dialysis, Inc.'s practice location is listed as: 1313 La Concha Ln Houston, TX 77054-1809 and can be reached via phone at (713) 668-2744.

Contact Information

NPI Number
1881701480
Website
Not provided

Address
1313 La Concha Ln
Houston, TX 77054-1809

Specialties


Business Information

Sole-Proprietor?
Not Available
Is Sub-Organization?
Not Available
Parent Organization Name
Not Applicable

About This listing

Last Updated
4/20/2008 16 years ago
Date Added
8/23/2006 18 years ago
Viewed On
9/12/2024 just now

End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility Taxonomy Info

The taxonomy code for Eumana Home Dialysis, Inc.'s main specialty, End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility, is 261QE0700X.

Click here to see more information about this taxonomy and find other providers that specialize in End-Stage Renal Disease (ESRD) Treatment Ambulatory Facility

Ratings

Be the first to rate Eumana Home Dialysis, Inc.

Overall
Professionalism
Facilities
Availability
Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.


Health Care Providers Nearby











Success

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.